Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03739775
NA

Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses (CIRCA-HPV)

Sponsor: Institut Curie

View on ClinicalTrials.gov

Summary

ctDNA detection in patients with previously treated, HPV-induced, stage II or III invasive pelvic cancer and who are currently in post-treatment follow-up.

Official title: Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

172

Start Date

2019-01-24

Completion Date

2026-06-01

Last Updated

2025-09-15

Healthy Volunteers

No

Interventions

PROCEDURE

Blood sampling

Patients will have a blood draw at each visit to the hospital and at least 6 months (+/- 1 month) intervals.

Locations (5)

CHU de Besançon

Besançon, France

Institut Curie - Paris

Paris, France

Hôpital Tenon

Paris, France

CHU Pontchaillou

Rennes, France

Institut Curie - Saint-Cloud

Saint-Cloud, France